Jordan Tuia

An analyst specializing in r programming, statistics, and data visualizations.




Projects / Work Samples

Analysis

Oncology trial endpoints
An analysis of endpoints for oncology drug trials, comparing outcomes for single agent vs. combination therapy

Analysis

CMS Data
A data processing walkthrough of creating a study dataset from disconnected databases. Includes: SQL, merges/linkage

Analysis

Markov Chain Monte Carlo
Simulates the Markov Chain Monte Carlo with visuals

Analysis

Survival Analysis
Deconstructing the calculations of survival probability in a recreation of typical R functions. Includes: HTML parsing and survival analysis
Shiny App

Breast cancer clinical data
An interactive shiny app exploring clinical data of breast tumors in relation to malignancy. Includes: binomial logistic regression, principal component analysis, correlation
Shiny App

LinkedIn job postings
An interactive shiny app exploring 2023 LinkedIn job postings. Includes: stratification, regex/natural language proccessing, logic checks

Visual/Design

Proposal Template
A designed proposal document template. Find the word document here

Visual/Design

Timeline of COVID vaccine votes
A data visualization timeline of the votes for the COVID vaccine
Analysis

Oncology drug costs
An quick analysis of oncology drug approvals, comparing average cost to various developmental factors
Visual/Design

Drug sequencing on tumor burden
A mockup of visual teaching aids illustrating possible drug effects on tumor burdens.



Publications

  1. Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review
    Patrick Crotty, Karim Kari, Griffin K Hughes, and 8 more authors
    Targeted Oncology, 2024
  2. Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis
    Michael Lam, Timothée Olivier, Alyson Haslam, and 2 more authors
    European Journal of Cancer, 2024
  3. Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials
    Brody Dennis, Chance Bratten, Griffin K Hughes, and 10 more authors
    BMJ Oncology, 2024
  4. Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy
    Sruthi Ranganathan, Alyson Haslam, Jordan Tuia, and 1 more author
    Journal of Cancer Policy, 2023
  5. Multiple Myeloma: Challenges with deciding the optimal sequencing strategy
    Anushka Walia, Alyson Haslam, Jordan Tuia, and 1 more author
    Frontiers in Pharmacology, 2023
  6. Cancer Drug Price and Novelty in Mechanism of Action
    Miloš D Miljković, Jordan Tuia, Timothée Olivier, and 2 more authors
    JAMA Network Open, 2023
  7. Assessing patient burden and benefit: A decade of cabozantinib clinical trials
    Griffin K Hughes, Nicholas B Sajjadi, Brooke Gardner, and 5 more authors
    International journal of cancer, 2023
  8. Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers
    Alyson Haslam, Timothée Olivier, Jordan Tuia, and 1 more author
    BMC cancer, 2023
  9. Systematic review and meta-analysis of randomized trials testing interventions to reduce physician burnout
    Alyson Haslam, Jordan Tuia, Sarah L Miller, and 1 more author
    The American Journal of Medicine, 2023
  10. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed
    Anushka Walia, Jordan Tuia, and Vinay Prasad
    Nature Reviews Clinical Oncology, 2023
  11. Eligibility for Human Leukocyte Antigen–Based Therapeutics by Race and Ethnicity
    Timothée Olivier, Alyson Haslam, Jordan Tuia, and 1 more author
    JAMA Network Open, 2023
  12. Cost of drug wastage from dose modification and discontinuation of oral anticancer drugs
    Michael Lam, Timothée Olivier, Alyson Haslam, and 2 more authors
    JAMA oncology, 2023
  13. Scoping Review of Published Oncology Meta-analyses in High-Impact Oncology Journals
    Alyson Haslam, Jordan Tuia, and Vinay Prasad
    JAMA Network Open, 2023
  14. Profile of the Oncology Physician Workforce and the Characteristics of Attrition
    Jordan Tuia, Alyson Haslam, and Vinay Prasad
    JCO Oncology Practice, 2023
  15. Interpretation of Wide Confidence Intervals in Meta-Analytic Estimates: Is the ‘Absence of Evidence’‘Evidence of Absence’?
    Sarah Miller, Jordan Tuia, and Vinay Prasad
    Available at SSRN, 2023
  16. Frequency and characteristics of trials using medical writer support in high-impact oncology journals
    Eva Buck, Alyson Haslam, Jordan Tuia, and 1 more author
    JAMA network open, 2023
  17. Eventual success rate and predictors of success for oncology drugs tested in phase I trials
    Alyson Haslam, Timothée Olivier, Kerrington Powell, and 2 more authors
    International Journal of Cancer, 2023
  18. Current landscape of disparity-focused research: a bibliometric analysis of 260 research articles
    Anushka Walia, Alyson Haslam, Jordan Tuia, and 2 more authors
    medRxiv, 2023
  19. A systematic review of basket and umbrella trials in oncology: the importance of tissue of origin and molecular target
    Alyson Haslam, Timothée Olivier, Jordan Tuia, and 1 more author
    European Journal of Cancer, 2023
  20. Association between US drug price and measures of efficacy for oncology drugs approved by the US Food and Drug Administration from 2015 to 2020
    Miloš D Miljković, Jordan Tuia, Timothee Olivier, and 2 more authors
    JAMA Internal Medicine, 2022
  21. Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care
    Jordan Tuia, Timothée Olivier, and Vinay K Prasad
    American journal of clinical oncology, 2022
  22. Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Enzalutamide Clinical Trials
    John K Stadler, Wyatt Compton, Griffin K Hughes, and 8 more authors
    In 7th Annual Joint Research Meeting: Biomedical, Biological, Neuroscience, Physiology, Forensics, 2023
  23. Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Ramucirumab Clinical Trials
    Adam Khan, Hassan Khan, Griffin Hughes, and 8 more authors
    In 7th Annual Joint Research Meeting, 2023
  24. A preliminary study of the rate of hospitals and satellite clinics worldwide for top US cancer centers
    Vinay Prasad, Alyson Haslam, and Jordan Tuia
    Journal of Cancer Policy, 2022
  25. Measuring the effectiveness of public involvement in transportation planning and project development
    Bruce Brown, Kate Gunby, Jamie Strausz-Clark, and 8 more authors
    NCHRP research report, 2019
  26. The promise and pitfalls of using crowdsourcing in research prioritization for back pain: cross-sectional surveys
    Matthew A Bartek, Anjali R Truitt, Sierra Widmer-Rodriguez, and 8 more authors
    Journal of medical Internet research, 2017



Certifications


Website visit count: